Cancer Research

Could This Mouse Make Antibody Drugs Safer?
Research & Development Could This Mouse Make Antibody Drugs Safer?

For decades, the path from a promising antibody discovery in the lab to a life-saving therapy for patients has been fraught with uncertainty. Many drugs that show incredible potential in early tests ultimately fail in human trials, costing billions and delaying medical progress. Today we're

When Do Our Immune Cells Turn Against Us?
Research & Development When Do Our Immune Cells Turn Against Us?

The human immune system stands as a formidable biological fortress, meticulously designed to identify and annihilate threats ranging from common viruses to nascent cancer cells, but a landmark analysis has illuminated a disturbing scenario where this defense system's own soldiers can be corrupted

Study Links Genetic Ancestry to Cancer Survival Gaps
Research & Development Study Links Genetic Ancestry to Cancer Survival Gaps

The stark reality that a patient's survival from head and neck cancer can differ by nearly double based on their ancestral background has long presented a profound challenge to the medical community, prompting a deeper search for answers beyond established social and economic factors. A

What Is the Antibody's Hidden Control Hub?
Research & Development What Is the Antibody's Hidden Control Hub?

Deep within the intricate architecture of the human immune system, a component long considered a minor structural element has now been revealed as a master switch capable of fundamentally rewriting the rules of engagement for our body's most prolific defender. For decades, the elegant Y-shaped

New Framework Targets Overlooked MET Fusions
Research & Development New Framework Targets Overlooked MET Fusions

A pivotal study in precision oncology is poised to reshape how clinicians approach cancers driven by specific genetic alterations, offering a detailed roadmap for identifying and treating mutations that have long been underrecognized. Led by Dr. Wei Yang and his team, the research introduces a

Dual-Action Cancer Vaccine Shows Promise in First Trial
Research & Development Dual-Action Cancer Vaccine Shows Promise in First Trial

A groundbreaking personalized cancer therapy that essentially teaches a patient's own immune system how to recognize and destroy their specific tumor has delivered remarkable results in its initial human trial, signaling a potential new era in the fight against advanced solid tumors. This

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later